Evidenzbasierte Musiktherapie Bei Bpsd

Musiktherapie bei Demenzerkrankungen Das Buch fragt nach dem aktuellen musiktherapeutischen Forschungsstand zum Umgang mit BPSD, beginnend mit der Wirkung auf die unterschiedlichen Symptomcluster inkl. einer zusammenfassenden Darstellung konkreter Interventionen und Therapiesettinginformationen. Untersucht wird das Thema an aktuellen klinischen Studien an der Psychiatrischen Privatklinik Sanatorium Kilchberg in der Schweiz von der Autorin Rahel Sutter, Musiktherapeutin MAS/SFMT unter medizinischer Leitung von Dr. med. Annkathrin Pöpel, Fachärztin für Psychiatrie, Psychotherapie und Neurologie, Dipl. Musiktherapeutin FH. Im Einleitungsteil werden die Grundlagen zu BPSD und deren Behandlungsmöglichkeiten und eine Übersicht zu den Indikationen von Musiktherapie bei Demenz und den unterschiedlichen Musiktherapie-Ansätzen gegeben. Der Ergebnisteil untermauert die aktuellen Behandlungsempfehlungen (Bezug zu der S-3 Leitlinie Demenz der DGPPN) und beinhaltet Informationen zur klinischen Anwendung.

With increasing urgency, decisions about the digitalized future of healthcare and implementations of new assistive technologies are becoming focal points of societal and scientific debates and addresses large audiences. Decisions require a careful weighing of risks and benefits and contextualizing in-depth ethical analysis with robust empirical data. However, up to now, research on social assistive technologies is mostly dispersed over different academic fields and disciplines. A comprehensive overview on discussions regarding values at stake and ethical assessment of recent developments especially in healthcare is largely missing. This publication initiates an interdisciplinary discourse on ethical, legal and social implications of socially assistive technologies in healthcare. Contributions include perspectives from nursing science, social sciences, philosophy, medical ethics, economics and law to present an – to our knowledge – first and comprehensive overview on different aspects of the use and implementation of socially assistive technologies from an ethical perspective. It combines practically relevant insights and examples from current research and development with ethical analysis to uncover exemplary moral tipping points between promotion of participation or well-being and risks and damages to these values. Healthcare professionals involved in implementation of smart technologies as well as scholars from the field of humanities, nursing and medicine, interested in the discussions on ethics and technology in healthcare, will benefit from this new contribution. The publication is part of the international DigitAs conference "Aging between Participation and Simulation – Ethical Dimensions of Socially Assistive Technologies" held at the Institute of Medical Ethics and History of Medicine (Ruhr University Bochum) from 4 February to 8 February 2019. Within this framework, twelve young scholars were invited to discuss their contributions with renowned experts in the field. The Institute of Medical Ethics and History of Medicine is one of the leading institutes in empirically informed ethical analysis in healthcare and medicine and is a member of the European Association of Centres of Medical Ethics (EACME).

This report presents national estimates of incontinence prevalence in the United States using data source specific definitions of incontinence among persons aged 65 years and over by sociodemographic characteristics during 2007-2010. The prevalence of incontinence is evaluated for non-institutionalized persons, those living in residential care facilities, and home health and hospice care recipients.

An extensive, multidisciplinary study of old age and aging, ranging from 70 to 100 years.

This manual provides the American Psychiatric Association's guidelines for the treatment of patients with major depressive disorder. It is divided into three sections, covering treatment recommendations; background information and review of available evidence; and future research needs. It seeks to summarize the specific forms of somatic, psychotherapeutic, psychosocial and educational treatments that have been developed to deal with major depressive disorder.